Zehra Özcan

486 total citations
33 papers, 327 citations indexed

About

Zehra Özcan is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zehra Özcan has authored 33 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zehra Özcan's work include Radiopharmaceutical Chemistry and Applications (6 papers), Pediatric Urology and Nephrology Studies (5 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Zehra Özcan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Pediatric Urology and Nephrology Studies (5 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Zehra Özcan collaborates with scholars based in Türkiye, United Kingdom and United States. Zehra Özcan's co-authors include Özgür Ömür, Peter J. Anderson, Zeynep Burak, Yeşim Ertan, Kamil Kumanlıoğlu, Dündar Sabah, Isky Gordon, Süha Süreyya Özbek, I. Gordon and Murat Fani Bozkurt and has published in prestigious journals such as The Journal of Urology, Annals of the Rheumatic Diseases and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Zehra Özcan

29 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zehra Özcan Türkiye 11 94 88 85 80 58 33 327
Manish Ora India 13 70 0.7× 41 0.5× 83 1.0× 154 1.9× 56 1.0× 71 434
Ihn Ho Cho South Korea 11 128 1.4× 110 1.3× 171 2.0× 48 0.6× 36 0.6× 29 368
Bircan Sönmez Türkiye 10 47 0.5× 32 0.4× 127 1.5× 60 0.8× 69 1.2× 42 340
J VEINOT Canada 7 157 1.7× 39 0.4× 118 1.4× 90 1.1× 49 0.8× 10 512
Virgilio Longari Italy 8 28 0.3× 176 2.0× 102 1.2× 75 0.9× 36 0.6× 20 434
William Erdman United States 11 117 1.2× 50 0.6× 154 1.8× 132 1.6× 107 1.8× 23 513
P D Radecki United States 10 92 1.0× 110 1.3× 246 2.9× 89 1.1× 38 0.7× 15 386
Regi Oommen India 10 58 0.6× 71 0.8× 95 1.1× 65 0.8× 62 1.1× 43 339
P.J.C. Brooman United Kingdom 11 61 0.6× 31 0.4× 89 1.0× 242 3.0× 51 0.9× 18 423
Hyewon Hyun United States 10 86 0.9× 55 0.6× 61 0.7× 46 0.6× 27 0.5× 24 278

Countries citing papers authored by Zehra Özcan

Since Specialization
Citations

This map shows the geographic impact of Zehra Özcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zehra Özcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zehra Özcan more than expected).

Fields of papers citing papers by Zehra Özcan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zehra Özcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zehra Özcan. The network helps show where Zehra Özcan may publish in the future.

Co-authorship network of co-authors of Zehra Özcan

This figure shows the co-authorship network connecting the top 25 collaborators of Zehra Özcan. A scholar is included among the top collaborators of Zehra Özcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zehra Özcan. Zehra Özcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bozkurt, Murat Fani & Zehra Özcan. (2018). The Evolving Role of Nuclear Medicine and Molecular Imaging: Theranostics and Personalized Therapeutic Applications. Molecular Imaging and Radionuclide Therapy. 27(1). 1–2. 9 indexed citations
2.
Makay, Özer, Murat Özdemir, Yasemin Giles Şenyürek, et al.. (2018). Surgical approaches for papillary microcarcinomas: Turkey’s perspective. Turkish Journal of Surgery. 34(2). 89–93. 7 indexed citations
3.
Özcan, Zehra. (2014). Radiosynovectomy in Hemophilic Synovitis. Molecular Imaging and Radionuclide Therapy. 23(1). 1–4. 9 indexed citations
4.
Fahlbusch, Fabian B., Zehra Özcan, Margarete Goppelt‐Struebe, et al.. (2010). Lack of α8 integrin leads to morphological changes in renal mesangial cells, but not in vascular smooth muscle cells. BMC Cell Biology. 11(1). 102–102. 15 indexed citations
5.
Ömür, Özgür, et al.. (2008). Concomitant Hyperthyroidism in Patients With Thyroid Carcinoma and the Effects of Iodine Supplementation in an Iodine-Deficient Area. Clinical Nuclear Medicine. 33(11). 769–772. 4 indexed citations
6.
Ömür, Özgür, et al.. (2008). Clinical Implications of Diffuse Hepatic Uptake Observed in Postablative and Post-Therapeutic I-131 Scans. Clinical Nuclear Medicine. 34(1). 11–14. 29 indexed citations
7.
8.
Ömür, Özgür, et al.. (2007). A comparative evaluation of Tl-201 and Tc-99m sestamibi myocardial perfusion spect imaging in diabetic patients. International journal of cardiac imaging. 24(2). 173–181. 3 indexed citations
9.
Özcan, Zehra, Peter J. Anderson, & Isky Gordon. (2006). Robustness of estimation of differential renal function in infants and children with unilateral prenatal diagnosis of a hydronephrotic kidney on dynamic renography: How real is the supranormal kidney?. European Journal of Nuclear Medicine and Molecular Imaging. 33(6). 738–744. 16 indexed citations
10.
Özbek, Süha Süreyya, et al.. (2004). Localization of Accessory Renal Artery Infarction Using Tc-99m DMSA Scintigraphy. Clinical Nuclear Medicine. 29(10). 649–651. 2 indexed citations
11.
Özcan, Zehra, Peter J. Anderson, & I. Gordon. (2004). PRENATALLY DIAGNOSED UNILATERAL RENAL PELVIC DILATATION: A DYNAMIC CONDITION ON ULTRASOUND AND DIURETIC RENOGRAPHY. The Journal of Urology. 172(4 Part 1). 1456–1459. 6 indexed citations
12.
Ömür, Özgür, et al.. (2003). Subacute Thyroiditis During Interferon Therapy for Chronic Hepatitis B Infection. Clinical Nuclear Medicine. 28(10). 864–865. 4 indexed citations
13.
Burak, Zeynep, et al.. (2002). The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer. Annals of Nuclear Medicine. 16(2). 103–108. 14 indexed citations
14.
15.
Burak, Zeynep, et al.. (2001). The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response. European Journal of Nuclear Medicine and Molecular Imaging. 28(9). 1341–1350. 26 indexed citations
17.
Özcan, Zehra, et al.. (2001). Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours. Nuclear Medicine Communications. 22(6). 679–683. 5 indexed citations
18.
Özcan, Zehra, et al.. (1999). False-Negative Scintigraphy With Tc-99m Sestamibi in Stage IV Neuroblastoma. Clinical Nuclear Medicine. 24(4). 267–270.
19.
Özcan, Zehra, et al.. (1999). Assessment of chemotherapy-induced changes in bone sarcomas. Nuclear Medicine Communications. 20(1). 41–48. 6 indexed citations
20.
Özcan, Zehra, Zeynep Burak, Coşkun Özcan, et al.. (1996). Is 201Tl a reliable agent in tumour imaging?. Nuclear Medicine Communications. 17(9). 805–809. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026